Europe iPSC Industry on Track for USD 1,111.97 Million Valuation by 2032
Market Overview Europe Induced Pluripotent Stem Cell (iPSC) Market size and share is currently valued at USD 500.62 million in 2023 and is anticipated to generate an estimated revenue of USD 1,111.97 million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 9.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032 The Europe Induced Pluripotent Stem Cell (iPSC) Market is witnessing strong growth driven by advancements in regenerative medicine, disease modeling, and drug discovery applications. Induced pluripotent stem cells, which are reprogrammed from adult somatic cells, offer an ethical and versatile alternative to embryonic stem cells. They possess the ability to differentiate into various cell types, making them valuable tools for understanding disease mechanisms and developing personalized therapies. Europe, with its well-established biomedical research in...